Drugs / SION-719
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07108153 | Nov 2025 → Jul 2026 overdue | cystic fibrosis | Sionna Therapeutics Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SION-719 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07108153 ↗ |